|
|
|
Event Videos
|
https://pubmed.ncbi.nlm.nih.gov/38874972/ Wilson disease Eur J Gastroenterol Hepatol. 2024 Aug 1;36(8):1046-1053. Analysis of risk factors for fatty liver disease in children with Wilson's disease Shu-Pei Jia 1 2, Mei-Xia Wang 2, Zhuang Tao 2, Yan-Nan Gao 2, Gu-Ran Yu 3, Wen-Ming Yang 2 DOI: 10.1097/MEG.0000000000002801 Background and aims: Many children with Wilson's disease are complicated with dyslipidemia. The aim of this study was to investigate the risk factors for the development of fatty liver disease (FLD) in children with Wilson's disease Published on:
Jun-2024
|
Please donate and help Mohsin get the treatment he urgently needs. child_picture:
Target Fund (Rs.):
500000
Deadline:
Mon, 2024-09-30 (All day)
Disease:
Wilson Disease
Name:
Mohsin Qayyum Shaikh
|
|
https://pubmed.ncbi.nlm.nih.gov/38929273/ Alpha1 antitripsin Children (Basel). 2024 Jun 6;11(6):694. Alpha-1-Antitrypsin Deficiency in Children-Unmet Needs Concerning the Liver Manifestation Joelle Lemke 1, Alexander Weigert 1, Soyhan Bagci 1 2, Mark Born 3, Rainer Ganschow 1, David Katzer 1 PMCID: PMC11202262 DOI: 10.3390/children11060694 Published on:
Jun-2024
|
https://pubmed.ncbi.nlm.nih.gov/38808600/ Autoimmune hepatitis Leptin gene Polymorphism and Leptin protein levels in Pediatric Autoimmune Hepatitis Samah M Awad 1, Hanaa M Elgazzar 1, Eman H Hassan 1, Esraa T Allam 2, Ahmed B Zaid 3, Sally W Elkhadry 4, Sara K Rizk 5, Dina S Fotoh 6, Tahany Abd El Hamid Salem 7 DOI: 10.1080/15321819.2024.2360083 Published on:
May-2024
|
|
https://pubmed.ncbi.nlm.nih.gov/38944185/ MASLD J Pediatr. 2024 Jun 27:114171. Adipose Tissue Insulin Resistance Correlates with Disease Severity in Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease: A Prospective Cohort Study Anneleen Heldens 1, Ellen Dupont 2, Lindsey Devisscher 3, Maarten Buytaert 1, Xavier Verhelst 1, Sarah Raevens 1, Hans Van Vlierberghe 1, Anja Geerts 1, Ruth De Bruyne 4, Sander Lefere 5 DOI: 10.1016/j.jpeds.2024.114171 Published on:
Jun-2024
|
https://pubmed.ncbi.nlm.nih.gov/38723644/ PFIC Lancet Gastroenterol Hepatol. 2024 May 6:S2468-1253(24)00080-3. Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Alexander G Miethke 1, Adib Moukarzel 2, et al DOI: 10.1016/S2468-1253(24)00080-3 Published on:
May-2024
|
|
https://pubmed.ncbi.nlm.nih.gov/38946635/ MASLD Saudi J Gastroenterol. 2024 Jun 28. The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia Saleh A Alqahtani 1 2 3, Faisal Abaalkhail 4, Saad Alghamdi 3, Khalid Bzeizi 3, Waleed K Al-Hamoudi 3 5, James M Paik 1 6, Linda Henry 1 6, Bandar Al-Judaibi 3, Faisal M Sanai 5 7, Zobair M Younossi 1 6 8 DOI: 10.4103/sjg.sjg_62_24 Published on:
Jun-2024
|
https://pubmed.ncbi.nlm.nih.gov/38771552/ NAFLD Review World J Pediatr. 2024 May 21. Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis Eun Joo Lee 1, Miyoung Choi 2, Sang Bong Ahn 3, Jeong-Ju Yoo 4, Seong Hee Kang 5, Yuri Cho 6, Do Seon Song 7, Hong Koh 1, Dae Won Jeon 8, Hye Won Lee 9 DOI: 10.1007/s12519-024-00814-1 Background: As childhood obesity escalates worldwide, the prevalence of nonalcoholic fatty liver disease (NAFLD) in pediatric and adolescent populations is also increasing. However, systematic studies and meta-analyses evaluating the prevalence of pediatric NAFLD remain limited. Published on:
May-2024
|
|
https://pubmed.ncbi.nlm.nih.gov/38957097/ cholestatic liver disease doi: 10.1097/MOP.0000000000001380. Online ahead of print. What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches Michele Pinon 1, Binita M Kamath DOI: 10.1097/MOP.0000000000001380 Purpose of review: To highlight recent advances in pediatric cholestatic liver disease, including promising novel prognostic markers and new therapies. Published on:
Jun-2024
|
https://pubmed.ncbi.nlm.nih.gov/38771552/ NAFLD Review World J Pediatr. 2024 May 21. Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis Eun Joo Lee 1, Miyoung Choi 2, Sang Bong Ahn 3, Jeong-Ju Yoo 4, Seong Hee Kang 5, Yuri Cho 6, Do Seon Song 7, Hong Koh 1, Dae Won Jeon 8, Hye Won Lee 9 DOI: 10.1007/s12519-024-00814-1 Background: As childhood obesity escalates worldwide, the prevalence of nonalcoholic fatty liver disease (NAFLD) in pediatric and adolescent populations is also increasing. However, systematic studies and meta-analyses evaluating the prevalence of pediatric NAFLD remain limited. Published on:
May-2024
|
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
